Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne A Phillips

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Cancer Research|September 11, 2013
Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progressionChristy L Trejo, Shon Green, Victoria Marsh, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Molecular epidemiology of and genetic susceptibility to esophageal cancerManisha Bajpai, Kiron M Das, Joel Lefferts, et al.
Developmental Biology|May 11, 2015
Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defectsLauren M Hare, Quenten Schwarz, Sophie Wiszniak, et al.
Oncotarget|December 22, 2017
PIK3CA<sup>H1047R</sup>-induced paradoxical ERK activation results in resistance to BRAF<sup>V600E</sup> specific inhibitors in BRAF<sup>V600E</sup> PIK3CA<sup>H1047R</sup> double mutant thyroid tumorsMatthias A Roelli, Dorothée Ruffieux-Daidié, Amandine Stooss, et al.
The Lancet. Oncology|December 19, 2015
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical interventionMaria-Pia Bernardi, Samuel Y Ngan, Michael Michael, et al.
Differentiation; Research in Biological Diversity|May 20, 2005
Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growthElizabeth Vincan, Phillip K Darcy, Mark J Smyth, et al.
Plos One|May 12, 2025
Ubiquitous expression of an activating mutation in the Pik3ca gene reprograms glucose and lipid metabolism in miceSabrina Caiazzo, Matthew J Watt, Garron T Dodd, et al.
Oncogene|May 10, 2022
Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancerAlexandra M Simond, Tung Bui, Dongmei Zuo, et al.
Oncotarget|April 28, 2017
Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivoOussama ElMokh, Dorothée Ruffieux-Daidié, Matthias A Roelli, et al.
Annals of Surgical Oncology|September 27, 2007
Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancerCuong Duong, Danielle M Greenawalt, Adam Kowalczyk, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Cancer Research|September 11, 2013
Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progressionChristy L Trejo, Shon Green, Victoria Marsh, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Molecular epidemiology of and genetic susceptibility to esophageal cancerManisha Bajpai, Kiron M Das, Joel Lefferts, et al.
Developmental Biology|May 11, 2015
Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defectsLauren M Hare, Quenten Schwarz, Sophie Wiszniak, et al.
Oncotarget|December 22, 2017
PIK3CA<sup>H1047R</sup>-induced paradoxical ERK activation results in resistance to BRAF<sup>V600E</sup> specific inhibitors in BRAF<sup>V600E</sup> PIK3CA<sup>H1047R</sup> double mutant thyroid tumorsMatthias A Roelli, Dorothée Ruffieux-Daidié, Amandine Stooss, et al.
The Lancet. Oncology|December 19, 2015
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical interventionMaria-Pia Bernardi, Samuel Y Ngan, Michael Michael, et al.
Differentiation; Research in Biological Diversity|May 20, 2005
Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growthElizabeth Vincan, Phillip K Darcy, Mark J Smyth, et al.
Plos One|May 12, 2025
Ubiquitous expression of an activating mutation in the Pik3ca gene reprograms glucose and lipid metabolism in miceSabrina Caiazzo, Matthew J Watt, Garron T Dodd, et al.
Oncogene|May 10, 2022
Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancerAlexandra M Simond, Tung Bui, Dongmei Zuo, et al.
Oncotarget|April 28, 2017
Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivoOussama ElMokh, Dorothée Ruffieux-Daidié, Matthias A Roelli, et al.
Annals of Surgical Oncology|September 27, 2007
Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancerCuong Duong, Danielle M Greenawalt, Adam Kowalczyk, et al.
Pageof 10